Cargando…
Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis
BACKGROUND: Hepatocellular carcinoma (HCC) is the third most fatal cancer, with a 5-year survival rate of 18%. Standard frontline-therapy is multikinase inhibitors (MKIs), but accessibility is still limited, particularly in developing countries. This network meta-analysis (NMA) aimed to compare the...
Autores principales: | Oranratnachai, Songporn, Rattanasiri, Sasivimol, Pooprasert, Anantaporn, Tansawet, Amarit, Reungwetwattana, Thanyanan, Attia, John, Thakkinstian, Ammarin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044881/ https://www.ncbi.nlm.nih.gov/pubmed/33869060 http://dx.doi.org/10.3389/fonc.2021.654020 |
Ejemplares similares
-
Treatment outcomes of advanced hepatocellular carcinoma in real‐life practice: Chemotherapy versus multikinase inhibitors
por: Oranratnachai, Songporn, et al.
Publicado: (2022) -
Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients
por: Khiewngam, Khantong, et al.
Publicado: (2023) -
Association between IRF6 and 8q24 polymorphisms and nonsyndromic cleft lip with or without cleft palate: Systematic review and meta‐analysis
por: Wattanawong, Kachin, et al.
Publicado: (2016) -
Cost-effectiveness analysis of mesh fixation techniques for laparoscopic and open inguinal hernia surgeries
por: Techapongsatorn, Suphakarn, et al.
Publicado: (2022) -
Mesh-fixation technique for inguinal hernia repair: umbrella review
por: Techapongsatorn, Suphakarn, et al.
Publicado: (2022)